{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:44:12Z","timestamp":1787071452418,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Oral isotretinoin is highly effective in all forms and grades of acne, even in lower dosages (&lt;0.5 mg\/kg\/day). There is a paucity of comparative data on the various low-dose regimens of oral isotretinoin in the Indian literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To assess and compare the efficacy and tolerability of two low-dose oral isotretinoin treatment regimens (20 mg daily and 20 mg alternate days) in moderate to severe acne vulgaris.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A total of 240 patients with moderate to severe acne vulgaris were selected and randomized into two groups and treated with a fixed dose of 20 mg of isotretinoin (Group A - daily and Group B - alternate days) for 24 weeks and followed up for 12 weeks post therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 234 patients completed the study. At the end of therapy, decrease in the total acne loads up to 98.99% (Group A) and 97.69% (Group B) was achieved from the baseline (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01), excellent response was observed in 98.3% (Group A) and 93.96% (Group B) patients (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.166). In the severe acne, Group A performed significantly better than Group B until the end of 36 weeks. While in the moderate acne, significant difference in the response between both groups was observed only up to 12 weeks. No serious side effect was observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Both isotretinoin regimens were well tolerated and found to be an effective treatment for moderate to severe acne vulgaris. However, in moderate acne 20 mg alternate day regimen may be preferred. A 20 mg daily regimen is a better choice for severe acne in terms of response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitation:<\/jats:title>\n                    <jats:p>Small sample size and short follow-up period.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/2229-5178.190505","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T03:19:58Z","timestamp":1473909598000},"page":"378-385","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris"],"prefix":"10.4103","volume":"7","author":[{"given":"Daulat Ram","family":"Dhaked","sequence":"first","affiliation":[{"name":"Department of Skin, VD and Leprosy, Sawai Man Singh (SMS) Medical College, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Singh","family":"Meena","sequence":"additional","affiliation":[{"name":"Department of Skin, VD and Leprosy, Sawai Man Singh (SMS) Medical College, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshul","family":"Maheshwari","sequence":"additional","affiliation":[{"name":"Department of Skin, VD and Leprosy, Sawai Man Singh (SMS) Medical College, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma Shankar","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Skin, VD and Leprosy, Sawai Man Singh (SMS) Medical College, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj","family":"Purohit","sequence":"additional","affiliation":[{"name":"Department of Skin, VD and Leprosy, Sawai Man Singh (SMS) Medical College, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260327","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1136\/bmj.f2634","article-title":"Acne vulgaris","volume":"346","author":"Dawson","year":"2013","journal-title":"BMJ"},{"key":"R2-20260327","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000067817","article-title":"Epidemiology of acne","volume":"206","author":"Dreno","year":"2003","journal-title":"Dermatology"},{"key":"R3-20260327","first-page":"577","article-title":"Prevalence of facial acne in adults","volume":"41","author":"Goulden","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R4-20260327","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/095466300750163708","article-title":"Acne scarring: Reviewing the need for early treatment of acne","volume":"11","author":"Layton","year":"2000","journal-title":"J Dermatol Treat"},{"issue":"Suppl 1","key":"R5-20260327","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sder.2010.04.004","article-title":"Medical and psychosocial impact of acne","volume":"29","author":"Fried","year":"2010","journal-title":"Semin Cutan Med Surg"},{"key":"R6-20260327","first-page":"1080","article-title":"Acne quality of life and patient satisfaction following treatment with tretinoin pump","volume":"8","author":"Fried","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"R7-20260327","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-4362.1994.tb01500.x","article-title":"Isotretinoin therapy in acne vulgaris: A 10-year retrospective study in Singapore","volume":"33","author":"Shahidullah","year":"1994","journal-title":"Int J Dermatol"},{"key":"R8-20260327","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1365-2133.2010.10152.x","article-title":"Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: A randomized, controlled comparative study","volume":"164","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"key":"R9-20260327","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0190-9622(08)80076-X","article-title":"Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990","volume":"24","author":"Pochi","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"R10-20260327","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2340\/00015555894752","article-title":"Clinical evaluation in acne","volume":"89","author":"Lid\u00e9n","year":"1980","journal-title":"Acta Dermato Venereol Suppl (Stockh)"},{"key":"R12-20260327","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM197902153000701","article-title":"Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid","volume":"300","author":"Peck","year":"1979","journal-title":"N Engl J Med"},{"key":"R13-20260327","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0190-9622(80)80074-0","article-title":"The treatment of severe cystic acne with 13-cis-retinoic acid: Evaluation of sebum production and the clinical response in a multiple-dose trial","volume":"3","author":"Farrell","year":"1980","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"R14-20260327","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0190-9622(82)70066-0","article-title":"Comparative effect of isotretinoin on acne and sebaceous gland secretion","volume":"6","author":"Goldstein","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"R15-20260327","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2133.1993.tb11850.x","article-title":"Isotretinoin for the treatment of acne vulgaris: Which factors may predict the need for more than one course?","volume":"129","author":"Stainforth","year":"1993","journal-title":"Br J Dermatol"},{"key":"R16-20260327","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0190-9622(98)70444-X","article-title":"The role of isotretinoin in the treatment of acne: Personal observations","volume":"39","author":"Leyden","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"R17-20260327","first-page":"180","article-title":"Isotretinoin: An Indian experience","volume":"67","author":"Sheth","year":"2001","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R18-20260327","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0378-6323.58672","article-title":"Efficacy of low-dose isotretinoin in acne vulgaris","volume":"76","author":"Sardana","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R19-20260327","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1468-3083.1998.tb00763.x","article-title":"Medium dose isotretinoin for the treatment of acne","volume":"11","author":"Hermes","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R20-20260327","first-page":"41","article-title":"Low-dose schema of isotretinoin in acne vulgaris","volume":"23","author":"Mandekou-Lefaki","year":"2003","journal-title":"Int J Clin Pharmacol Res"},{"key":"R21-20260327","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","article-title":"Low-dose isotretinoin in the treatment of acne vulgaris","volume":"54","author":"Amichai","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R22-20260327","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00403-007-0777-2","article-title":"Treatment of acne with intermittent and conventional isotretinoin: A randomized, controlled multicenter study","volume":"299","author":"Akman","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"R23-20260327","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1468-3083.2008.03022.x","article-title":"Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris","volume":"23","author":"Sardana","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R24-20260327","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4103\/0378-6323.86482","article-title":"Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial","volume":"77","author":"Agarwal","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R25-20260327","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/11539570-000000000-00000","article-title":"Combination of low-dose isotretinoin and pulsed oral azithromycin in the management of moderate to severe acne: A preliminary open-label, prospective, non-comparative, single-centre study","volume":"31","author":"De","year":"2011","journal-title":"Clin Drug Investig"},{"key":"R26-20260327","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4103\/1947-489X.210559","article-title":"Daily Low Dose versus Intermittent Isotretinoin Regimens","volume":"5","author":"El-Sherif","year":"2013","journal-title":"Ibnosina J Med BS"},{"key":"R27-20260327","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/0019-5154.131455","article-title":"Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris","volume":"59","author":"Rao","year":"2014","journal-title":"Indian J Dermatol"},{"key":"R28-20260327","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000182270","article-title":"Acute acne flare following isotretinoin administration: Potential protective role of low starting dose","volume":"218","author":"Borghi","year":"2009","journal-title":"Dermatology"},{"key":"R29-20260327","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1067\/mjd.2001.117730","article-title":"An analysis of reports of depression and suicide in patients treated with isotretinoin","volume":"45","author":"Wysowski","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"R30-20260327","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0190-9622(83)80154-6","article-title":"Depression-a side effect of 13-cis-retinoic acid therapy","volume":"9","author":"Hazen","year":"1983","journal-title":"J Am Acad Dermatol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01630814-201607050-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:46:20Z","timestamp":1787067980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01630814-201607050-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/2229-5178.190505","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}